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DNA double-strand breaks are repaired through either non-homologous end joining (NHEJ) or homologous recombination repair 
(HRR) pathway. The well-characterized regulatory mechanisms of double-strand break repair (DSBR) are mainly found at the 
level of complicated repair protein interactions and modifications. Regulation of DSBR at the transcriptional level was also re-
ported. In this study, we found that DSBR can be regulated by miR-34a at the post-transcriptional level. Specifically, miR-34a, 
which can be activated by DNA damages, represses DSBR activities by impairing both NHEJ and HRR pathways in cultured cells. 
The repression is mainly through targeting the critical DSBR promoting factor SIRT1, as ectopically expressed SIRT1 without 
3′-UTR can rescue the inhibitory roles of miR-34a on DSBR. Further studies demonstrate that SIRT1 conversely represses 
miR-34a expression. Taken together, our data show that miR-34a is a new repressor of DSBR and the mutual inhibition between 
miR-34a and SIRT1 may contribute to regulation of DNA damage repair. 
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MicroRNAs (miRNAs) are posttranscriptional regulatory 
molecules that have been implicated in a wide variety of 
normal physiological processes and many human diseases 
[1,2]. These small non-coding RNAs (~20–22 nt) exert 
functions by site-specific targeting of untranslated regions 
located at either end of mRNA molecules. MiRNAs have 
been shown to finely tune gene expression and exert fail- 
safe functions. It has been proposed that positive and nega-
tive transcriptional coregulation of a miRNA and its targets 
is prevalent in the human and mouse genomes [3]. Such 
fine-tuning mechanisms may provide potential coordinated 
regulation and robustness of certain cellular functions in 
animal system [4]. 
DNA double-strand break repair (DSBR) is a complex 
multistep process under coordinated regulation, as dysregu-
lation of DSBR underpins many human diseases and even 
predisposes individuals to tumorigenesis [5]. There are two 
main pathways to repair DSBs: non-homologous end join-
ing (NHEJ) or homologous recombination repair (HRR) [6]. 
The process of DSBR encompasses gene-expression regula-
tion at the transcriptional and post-translational levels 
[7–11]. The extensive roles of miRNA in diverse patho-
physiological processes suggest an exquisite network may 
also exist for posttranscriptional controls over DSBR. One 
recent study showed that miR-24-mediated downregulation 
of H2AX suppresses DNA repair in terminally differentiat-
ed blood cells [12].  
SIRT1 has recently been regarded as a critical player in 
DNA damage repair [13]. A study using DNA strand break 
repair reporter system in cell lines showed that ectopically 
expressed SIRT1 resulted in increased repair of strand 
breakage, while repression of endogenous SIRT1 by siRNA 
led to decrease of repair activity [14]. Other two recent 
studies using primary MEFs or ES cells also confirmed that 
SIRT1 can localize to break site and is required for efficient 
DSBR. Knock-out or depletion of SIRT1 resulted in im-
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paired nuclear foci formation of RAD51, NBS1, and greatly 
decreased repair activity [15,16].  
In this study, we observed that miR-34a represses plas-
mid re-ligation activity as well as repair of etoposide in-
duced genomic DSBs. In addition, miR-34a inhibits ho-
mologous recombination (HR) mediated repair of I-SceI 
induced DSBs. Further rescue experiments showed that re-
pression of miR-34a on DSBR is mediated by targeting 
SIRT1. Finally, SIRT1 was shown to inversely down-  
regulate expression of miR-34a. These data indicate that the 
mutual inhibition between miR-34a and SIRT1 contributes 
to the regulation of DSBR. 
1  Materials and methods 
1.1  Cell Culture 
HeLa, 293T, HEK-293 and MCF-7 cells were maintained in 
DMEM media (Invitrogen) supplemented with 10% FBS. 
HEK-293A cells were maintained in α-MEM media (Invi-
trogen) supplemented with 10% FBS.  
1.2  Plasmid construction 
Genomic regions containing pri-miR-34s and flanking se-
quences were PCR amplified from HeLa cell genome and 
inserted into pCR3.1-Uni to construct pCR3.1-34a expres-
sion plasmid. The promoter regions of miR-34a and miR- 
34b/c loci were PCR amplified from HeLa cell genome and 
inserted into pGL3-basic to generate pGL3-34ap and pGL3- 
34bcp. The 3′-UTR fragments of SIRT1 and other repair 
factors were cloned into pGL3cM vector. The correspond-
ing seed regions were then mutated using QuikChange 
method. For expression of miR-34a and SIRT1 through 
adenovirus, the corresponding genomic region of pri-miR- 
34a or SIRT1 cDNA was cloned into pAd-Track-CMV and 
then shuttled into pAdEasy-1 followed by PacI digestion 
and transfection into HEK-293A cells [17]. The first gener-
ation viruses were harvested 7–8 d later.  
1.3  Luciferase assay 
HeLa, 293T or HEK-293 cells were plated at (0.5–1) ×104 
per well in 24-well plates. On the next day, 100 ng pGL3- 
34ap plasmids were transfected into SIRT1-RNAi or Con-
trol-RNAi cells using Lipofectamine 2000 (Invitrogen). For 
3′-UTR reporter assay, 100 ng 3′-UTR plasmids were 
transfected along with 600 ng miR-34a expression plasmids. 
For plasmid re-ligation assay, 100 ng Eco RI-linearized 
pGL2-Luc plasmids or the circular pGL2-Luc plasmids 
were transfected along with 600 ng miR-34a expression 
plasmids. Forty-eight hours later, cells were harvested and 
luciferase assays were performed by using Dual Luciferase 
Reporter Assay system (Promega). 
1.4  Neutral comet assay 
After adenovirus infection for 48 h, HeLa cells were treated 
with 50 μmol etoposide for 1 h. Cells were then collected 
and processed according to the procedures of neutral comet 
assay that specifically detects DNA double strand breaks 
[18]. The experiment was repeated three times and the data 
were analyzed by using CometScore (TriTek). 
1.5  Cell cycle and apoptosis analysis 
The cells after different treatments were trypsinized, col-
lected by centrifugation and fixed in 70% ethanol. After two 
washes in PBS, cells were treated with RNaseA and stained 
with propidium iodide for analysis by flow cytometry. 
SubG1 phase was measured to represent apoptotic cells. 
1.6  RNA interference 
The sense strand for shRNA of SIRT1 is 5′-GATGAAGTT- 
GACCTCCTCA-3′ [19], and the shRNA oligos were ligated 
into pXSN-mU6 [20]. The pXSN-shSIRT1 or pXSN-shGFP 
plasmids were trasnfected into GP293 cells along with 
pVSV-G to generate retroviruses. After infection, 600 μg/mL 
of G418 was used to generate stable knockdown cell lines. 
1.7  qRT-PCR and miRNA real-time PCR 
Total RNA was isolated by using Trizol (Invitrogen) rea-
gent and reverse transcription was performed per the manu-
facturer’s manual (New England Biolab). Real-time PCR 
was performed using SYBR Premix Ex Taq (TaKaRa) on 
Bio-Rad iQ5 cycler. Reverse transcription using stem-loop 
primers and real-time PCR of miR-34a and U6 RNA were 
performed as previously described [21]. The primer se-
quences are as follows: 
>RT primer for human U6 (RT-U6)  
5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGC- 
ACTGGATACGACAAAAATATG-3′  
>RT primer for hsa-miR-34a (RT-34a)  
5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGC- 
ACTGGATACGACAACAAC-3′. 
Q-PCR-primer sequences are as follows:  
>Forward primer for human u6 (qU6-F): 5′-GCGCGT- 
CGTGAAGCGTTC-3′  
>Reverse primer for human u6 (qmiR-R): 5′-GTGCA- 
GGGTCCGAGGT-3′  
>Forward primer for hsa-miR-34a (q34a-F): 5′-GCGCT- 
GGCAGTGTCTTAGC-3′  
>Reverse primer for hsa-miR-34a (qmiR-R): 5′-GTGCA- 
GGGTCCGAGGT-3′. 
1.8  Chromatin immunoprecipitation (ChIP) 
ChIP experiments were performed as described by the Up-
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state protocol with some modifications. After crosslinking 
with formaldehyde, nuclei were isolated and lysed in SDS 
lysis buffer (1% SDS, 10 mmol EDTA and 50 mmpol Tris, 
pH 8.1) and sonicated with Branson 150 sonicator to 
achieve fragment size of 200–750 bp. SIRT1 antibody (sc- 
15404, Santa Cruz) was used for immunoprecipitation. The 
primers were used to amplify the promoter region of hsa- 
miR-34a gene locus and the forward and reverse sequences 
are 5′-ACGGACTGAGAAACACAAGCG-3′ and 5′-CTTC- 
TCGGTGACCACGCAG-3′ respectively. The primers for 
GAPDH promoter are 5′-TACTAGCGGTTTTACGGGCG-3′ 
and 5′-TCGAACAGGAGGAGCAGAGAG-3′ respectively. 
1.9  Immunoblotting and antibodies 
Cells were lysed with RIPA buffer (50 mmol Tris-HCl, pH 
8, 150 mmol NaCl, 1% NP-40, 0.5% sodium deoxycholate, 
0.1% SDS, protease inhibitor cocktail from Sigma). Ku70 
antibody (sc-1486) and SIRT1 antibody (sc-15404) were 
obtained from Santa Cruz Biotechnology, Inc. RAD51 an-
tibody (PC130, Ab-1) was manufactured by Calbiochem. 
Anti-β-actin antibody was from Sigma. 
1.10  Statistical analysis 
Unpaired t-test analysis with two-tailed P-value was per-
formed with the GraphPad Prism 5 software (GraphPad 
Software, San Diego, CA). 
2  Results 
2.1  MiR-34a represses DSBR by impairing both NHEJ 
and HRR pathways 
MiR-34a has recently been shown to response to p53 and 
serve as a tumor suppressor [22–27]. Treatment of MCF-7 
cells with low dose of DNA damaging agents, etoposide 
(VP16) or H2O2, apparently induces miR-34a expression 
(Figure S1), suggesting that miR-34a may involve in the 
regulation of DSBR. 
NHEJ is one of the major processes for repairing DSBs, 
so we first determined whether miR-34a can affect DSBR 
through this pathway. To this end, we constructed expres-
sion vectors of human miR-34s and confirmed their expres-




Figure 1  MiR-34a represses DSBR activity by affecting NHEJ and HRR pathways. (a) MiR-34a expression plasmids or control plasmids were transfected 
into HeLa cells, and γ-32P labeled anti-miR-34a oligo DNA probes (5′-ACAACCAGCTAAGACACTGCCA-3′) were used to detect miR-34a expression. 5S 
RNA served as loading control. (b) MiR-34a expression plasmids were transfected into HeLa cells along with either circular or EcoRI-linearized pGL2-Luc 
plasmids and luciferase activity was measured 60 h post-transfection. Luciferase activity was normalized to Renilla Luciferase. Three independent experi-
ments were performed and results were represented as mean ± SD. (c) HeLa cells infected with Ad-GFP or Ad-miR-34a adenoviruses were treated with 50 
μmol/L etoposide or DMSO for 1 h. Cells were then harvested for neutral comet assay. Representative pictures were shown here and the data were analyzed 
from three independent experiments (>100 cells were analyzed). Olive tail moment was used to measure the amount of DSBs, and the data were shown as 
mean ± SEM. Unpaired t-test was performed by GraphPad Prism and *** means P<0.001. (d) MiR-34a expression plasmids or control plasmids were trans-
fected into DR-HEK-293 cells for 24 h followed by transfection with pI-SceI, and the cells were harvested 72 h after the first transfection for flow cytometry 
analysis. 
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plasmid re-ligation assay using pGL2-Luc vectors that were 
linearized with Eco RI. Since Eco RI cuts pGL2-Luc at the 
coding region, precise re-ligation is needed for restoration 
of luciferase activity. Upon ectopic expression of miR-34a, 
the re-ligation efficiency of the damaged plasmids was re-
duced by about 20% (Figure 1(b)). The luciferase activities 
of control circular plasmids were not affected by the ex-
pression of miR-34a, which indicates specific inhibitory 
effects of miR-34a on ligation of damaged plasmids. These 
data demonstrate that miR-34a reduces the microhomology- 
mediated precise end joining. 
Then we examined whether miR-34a affects the repair of 
genomic DSBs caused by DNA damaging agents. To intro-
duce DSBs, low dose of etoposide was adopted, and DSBR 
activity was measured by neutral comet assay. The results 
showed that ectopic expression of miR-34a led to about 
two-fold decrease of DSBR (increased comet tail moment) 
compared to the Ad-GFP group (Figure 1(c)).  
Finally, we investigated whether miR-34a affects HRR 
pathway. The DR-GFP reporter system [28] was applied for 
this purpose. HEK-293 cells with stable integration of 
DR-GFP reporter were transfected with miR-34a expression 
plasmids or control plasmids followed by transfection with 
I-SceI-expressing plasmids 24 h later. Flow cytometry 
analysis showed that miR-34a reduced the efficiency of 
I-SceI induced HRR of mutated DR-GFP reporter by two 
folds (Figure 1(d)). Meanwhile, the vector only group was 
included to represent spontaneous recombination events 
(Figure 1(d)).  
2.2  Repression of DSBR by miR-34a is independent of 
the pro-apoptotic activity 
Overexpression of miR-34a has the potential to induce cell 
apoptosis, which may interfere with the detection of DNA 
repair. Therefore, we examined if miR-34a at the level we 
used for DNA repair assay affected cell growth. Ectopic 
expression of miR-34s in HeLa cells at the levels we used, 
however, did not change phase distribution of cell cycle or 
cause apoptosis (Figure 2(a) and (b)). These results showed 
that inhibition of DSBR activity caused by miR-34a in 
HeLa cells is independent of the pro-apoptotic effects. 
2.3  Inhibitory effects of miR-34a on DSBR is mediated 
by targeting SIRT1 
Since SIRT1 is a critical DSBR promoting factor that has 
also been identified as a miR-34a target in HCT116 and 
PC3 cells [29,30], it may be responsible for repression ef-
fects of miR-34a on DSBR. Immunoblot analysis showed 
that miR-34a decreased SIRT1 protein level significantly 
but did not apparently affect the expression of Ku70 and 
RAD51 (Figure 3(a)), which are also critical players for 
NHEJ and HRR respectively. SIRT1 mRNA level was also 
observed to be slightly decreased upon miR-34a expression  
 
Figure 2  MiR-34a does not induce apoptosis in HeLa cells. HeLa cells 
transfected with miR-34a expression vectors were harvested 72 h post- 
transfection for flow cytometry analysis. The distribution of cell cycle 
phases was shown in the stacked bar graph (a) and the sub-G1 portion was 
also displayed (b). 
(Figure 3(b)). Luciferase assay further confirmed that miR- 
34a directly targeted wild type SIRT1 3′-UTR but not the 
miR-34a binding-site-mutated form (Figure 3(c)).  
To further prove that miR-34a represses DSBR by tar-
geting SIRT1, we performed DNA repair assays by co- 
transfecting SIRT1 cDNA without 3′-UTR. Plasmid re-  
ligation assay showed that upon introduction of SIRT1 
cDNA, the ligation efficiency was significantly restored 
(Figure 3(d)). Neutral comet assay showed that the low- 
dose etoposide induced DSBs were repaired more efficiently 
in SIRT1 expression group (decreased comet tail moment) 
compared with the miR-34a only group (Figure 3(e)). DR- 
GFP reporter assay by flow cytometry also showed that 
exogenous SIRT1 expression, as expected, can partially 
rescue the inhibitory effect of miR-34a on HRR (Figure 
3(f)). Taken together, it was concluded that miR-34a re-
presses DSBR activities mainly by targeting SIRT1. 
2.4  SIRT1 inversely represses expression of miR-34a 
MicroRNAs often co-regulate with their targets to realize 
fine-tuning of certain cellular functions [3], so it is intri-
guing to test if SIRT1 can inversely regulate expression of 
miR-34a. First, the specific inhibitor of SIRT1, Sirtinol was 
used to treat HEK-293 cells and miR-34a expression was 
observed to be increased (Figure 4(a)). Second, ectopic  
expression of dominant-negative SIRT1 (H363Y) form, 
which lacks catalytic deacetylase activity caused by H-to-Y  
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Figure 3  Repression of miR-34a on DSBR is mediated by targeting SIRT1. (a) HeLa cells infected with Ad-miR-34a or control Ad-GFP viruses were 
harvested 72 h post infection and Western blot was performed to detect Ku70, RAD51 and SIRT1 expression, and β-actin served as loading control. (b) 
Samples indicated in (a) were analyzed for SIRT1 mRNA level by qRT-PCR and results were shown as mean ± SD. Expression level was normalized to 
GAPDH. (c) The reporter plasmids containing wild-type (wt UTR) or miR-34-site-mutated (mut UTR) fragments of SIRT1 3′-UTR were transfected into 
HeLa cells along with miR-34a expression plasmids. Relative luciferase activities were measured and shown as mean ± SD. (d) MiR-34a and SIRT1 (with-
out 3′-UTR) expression plasmids were co-transfected into HeLa cells along with either circular or EcoRI-linearized pGL2-Luc plasmids. The data were 
analyzed as in Figure 1(b). (e) HeLa cells co-infected with Ad-GFP and Ad-miR-34a, or Ad-SIRT1 (without 3′-UTR) and Ad-miR-34a adenoviruses were 
treated with 50 μmol/L etoposide or DMSO for 1 h. Neutral comet assay was performed and analyzed as in Figure 1(c). (f) SIRT1 (without 3′-UTR) and 
miR-34a expression plasmids were co-transfected into DR-HEK-293 cells for 24 h followed by transfection with pI-SceI, and the flow cytometry analysis 
was performed as in Figure 1(d). 
mutation at position 363 of human SIRT1 protein, also 
caused up-regulation of miR-34a (Figure 4(b)). Subse-
quently, the promoter activity of miR-34a was evaluated in 
SIRT1-RNAi cells (Figure 4(c) and (d)). The results showed 
that miR-34a promoter activity increased in SIRT1-RNAi 
cells (Figure 4(e)). ChIP experiment also detected that 
SIRT1 can be recruited to the promoter region of miR-34a 
gene (Figure 4(f)). RT-PCR analysis further showed that 
endogenous miR-34a expression was up-regulated upon 
SIRT1 knockdown (Figure 4(g)). Therefore SIRT1 nega-
tively regulates miR-34a expression, and the two forms 
negative co-regulation relationship, which potentially regu-
lates DSBR activity. 
3  Discussion 
MiRNAs participate in diverse biological processes in 
plants and animals, and it is possible that positive and nega-
tive coregulation of miRNA and its targets widely exist [3]. 
Such characteristics may reflect functional diversity and 
fine-tuning regulation by miRNAs. The extensive roles of 
miRNA suggest that an exquisite network may contribute to 
posttranscriptional regulation of DSBR.  
In this study, we have verified that miR-34a has inhibi-
tory roles on DSBR. As for the NHEJ pathway, decreased 
repair efficiency of EcoRI-linearized plasmid DNA (pGL2- 
Luc) and etoposide induced genomic DSBs were detected 
upon ectopic expression of miR-34a (Figure 1(b) and (c)). 
As the central player of NHEJ pathway, Ku70 expression 
was detected by immunoblot and no apparent changes were 
observed (Figure 3(a)). The 3′-UTR of Ku70 was also 
scanned by TargetScan [31] and no potential miR-34s 
binding sites were found. We reasoned that the impaired 
genomic DSBR is ascribed to inhibition of SIRT1 by 
miR-34a, and this was then supported by the rescue experi-
ment in which exogenous SIRT1 cDNA without 3′-UTR 
was introduced (Figure 3(e)). In addition, miR-34a also 
suppresses HRR of DSBs induced by I-SceI at the chromo-
somal DR-GFP loci. Although miR-34a has putative target-
ing site at 3′-UTR of RAD51 (Figure S2), it has very mild 
effects on protein level of RAD51 (Figure 3(a)). Thus, the 
inhibitory effect of miR-34a on HRR is independent of 
RAD51. Introduction of SIRT1 cDNA without 3′-UTR,  
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Figure 4  SIRT1 down-regulates MiR-34a expression. (a) and (b) HEK-293 cells were treated with 30 μmol/L Sirtinol or transfected with domi-
nant-negative SIRT1 (HY), and MiR-34a expression was detected by qRT-PCR and normalized to U6 snRNA. (c) SIRT1 mRNA level was detected in 
SIRT1-RNAi cells and Control-RNAi cells, and normalized to GAPDH. (d) SIRT1 protein level was analyzed by immunoblot assay and β-Actin served as 
loading control. (e) MiR-34a promoter reporter plasmids or pGL3-basic plasmids were transfected into SIRT1-RNAi cells or control cells and luciferase 
activities were measured. Results are represented as mean ± SD. (f) ChIP experiment was performed using SIRT1 antibody or normal IgG, and miR-34a 
promoter region was amplified by PCR. The amplified promoter region of MiR-34a contains p53 binding site. GAPDH promoter served as negative control. 
(h) Schematic presentation was shown to depict mutual inhibition between MiR-34a and SIRT1, and their roles in regulating DSBR. (g) MiR-34a expression 
level in SIRT1-RNAi or control cells was analyzed by qRT-PCR as described in (a). 
however, can partially rescue the inhibitory effect by miR- 
34a, suggesting that miR-34a suppresses HRR by targeting 
SIRT1 (Figure 3(f)). A recent study by Uhl et al. [32] also 
proved that SIRT1 activity promotes HRR in human cells, 
and this effect is independent of RAD51 but depends on 
Werner helicase. Therefore, miR-34a regulates DSBR at the 
upstream level by affecting SIRT1 expression. 
SIRT1 was shown here to downregulate miR-34a by be-
ing recruited to the promoter region (Figure 4(g)). This 
makes it possible that SIRT1 and p53 counteract in regulat-
ing miR-34a expression in response to DNA damages. Up-
on DSBs formation, p53 is activated by phosphorylation 
and then functions as a “molecular node” in the DNA- 
damage response. p53 represses HRR via direct interaction 
with and inhibition of RAD51 and this is independent of 
p53 transactivation function [33,34]. Activated wild-type 
p53 can also suppress NHEJ although such a function and 
underlying mechanisms still bear debates [35]. In this study 
we found that p53-transactivated miR-34a inhibits DSBR 
by targeting SIRT1 at the posttranscriptional level (Figure 
3). The inhibition of DSBR by miR-34a adds new contents 
to functional network of p53. In summary, the activation of 
miR-34a by DSBs and repression by SIRT1 may contribute 
to modulating DNA repair activity and balancing cellular 
responses to different genotoxic stress (Figure 4(h)).  
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Figure S1  Low-dose etoposide (VP16) and H2O2 induce miR-34a expression in MCF-7 cells. 
Figure S2  MiR-34a potentially targets RAD51 3′-UTR. MiR-34s used in these assays were expressed from pMSCV-IRES-Puro (PIG) constructs. 
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